Efficacy and Safety Study of Budesonide to Treat Oral Chronic Graft vs Host Disease (cGvHD)

Clinical trial NCT00887263 · COMPLETED

Trial details

NCT number: NCT00887263
Sponsor: Dr. Falk Pharma GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Oral Chronic Graft vs Host Disease

Start date: 2009-03-01
Primary completion: 2015-10-01
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.